Gil Kraiem News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Gil kraiem. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Gil Kraiem Today - Breaking & Trending Today

IoT Pioneer Wiliot Secures $200 Million Investment Round Led by SoftBank Vision Fund 2

IoT Pioneer Wiliot Secures $200 Million Investment Round Led by SoftBank Vision Fund 2
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

New York , United States , Palo Alto , San Francisco , Noord Holland , Sayaka Morizono , Pranav Rastogi , Ap Moller Maersk , Avery Dennison , Amit Lubovsky , Belinda Chan , Daniel Griffin , Yanni Pipilis , Gil Kraiem , Samsung Venture Investment Corp , Softbank Group Corp , Qualcomm Ventures , Amazon Web Services Inc , Merck Kga , Softbank Vision Fund , Avery Dennison Corporation , Verizon Communications Inc , Fund Of Funds , Ntt Docomo , Merck Kgaa , With Softbank ,

Kadimastem Announces Executive Management Changes


Kadimastem Announces Executive Management Changes
USA - English
Accomplished US Life Science and Biotech Executive Asaf Shiloni Named New CEO
Company Appoints Biotech Industry Leaders Ronen Twito, CPA as Co-Chairperson and Doron Birger and Ron Mayron to the Company s Board of Directors
News provided by
Share this article
NESS ZIONA, Israel, Feb. 1, 2021 /PRNewswire/  
Kadimastem Ltd. (TASE: KDST), a clinical stage cell therapy company, announces the appointment of Asaf Shiloni as CEO. This follows a series of executive management appointments in the last month including Mr. Ronen Twito, CPA, as Co-Chairperson of Kadimastem s Board of Directors, and new expert Board members, Mr. Doron Birger and Mr. Ron Mayron. All are highly accomplished biotechnology industry experts, dedicated to working in concert to secure a bright future for the company. ....

Israel General , City Of , United Kingdom , Hebrew University , Tel Aviv , Doron Birger , Yossi Nizhar , Ronen Twito , Bioblast Pharma , Ron Mayron , Asaf Shiloni , Gil Kraiem , Company Contacts , London Stock Exchange , Weizmann Institute Of Science , Kadimastem Co , Ben Gurion University , College Of Management Academic , Teva Pharmaceutical Industries , Tel Aviv Stock Exchange , Tel Aviv University , Must Have Communications , Professor Michel Revel , Chief Scientist , Israel Prize , Accomplished New Directors ,

IGIN introduces a smart device for putting on sterile gloves automatically and easily


IGIN introduces a smart device for putting on sterile gloves automatically and easily
USA - English
News provided by
Share this article
Share this article
TEL-AVIV, Israel, Jan. 12, 2021 /PRNewswire/ The Israeli start-up company IGIN Tech, of the AIDOR Group, has developed a smart device for putting on sterile gloves automatically and quickly, without human touch.
The gloves are worn by inserting both hands into the device, which is based on development of the amorphous structure of the material of the glove. The system fits the glove to the user s hand quickly and easily, in a matter of seconds, and is intended for medical staff, laboratories, clean rooms in manufacturing plants (pharma, food, chips), airports, and more.   ....

United Arab Emirates , Gil Kraiem , Aidor International , Orna Goldberg , ஒன்றுபட்டது அரபு அமீரகங்கள் , ஓர்நா கோல்ட்பர்க் ,

Kadimastem Announces Encouraging Results of Cohort B of its Phase 1/2a Clinical Trial of AstroRx® for ALS


Kadimastem Announces Encouraging Results of Cohort B of its Phase 1/2a Clinical Trial of AstroRx® for ALS
USA - English
No treatment-related serious adverse events nor dose-limiting toxicities were reported during the 6- month post-treatment follow up
Clinically meaningful decline in disease progression was observed during the first 3-month of the 6-month follow up period, consistent with the results reported previously for Cohort A
News provided by
Share this article
Share this article
NESS ZIONA, Israel, Dec. 15, 2020 /PRNewswire/  Kadimastem Ltd. (TASE: KDST), a clinical stage cell therapy company, announced today encouraging results of Cohort B of its Phase 1/2a clinical trial of AstroRx ....

Israel General , Ein Kerem , Tel Aviv , Marc Gotkine , Yossi Nizhar , Gil Kraiem , Company Contacts , Therapy Development Institute , Foundation For Life , Hadassah Medical Center , Weizmann Institute Of Science , Department Of Neurology At Hadassah Medical Center , Tel Aviv Stock Exchange , Must Have Communications , Rating Scale Revised , Principal Investigator , Michel Revel , Embryonic Stem Cells , Amyotrophic Lateral Sclerosis , Lateral Sclerosis , Development Institute , Human Embryonic Stem Cells , Professor Emeritus , Molecular Genetics , Weizmann Institute , Professor Revel ,